GlobeNewswire 02-20 Celcuity Appoints Eldon Mayer as Chief Commercial Officer
GlobeNewswire 02-01 PRISM MarketView Marks World Cancer Day
GlobeNewswire 2022-03-23 Emergent BioSolutions Provides Corporate Governance Update
GlobeNewswire 2020-06-24 Cytovia Therapeutics, Inc Adds Two Industry Leaders to Its Board of Directors
GlobeNewswire 2019-12-02 COGNOA APPOINTS SEASONED BIOTECH EXECUTIVE AS CFO
GlobeNewswire 2019-11-07 Aclaris Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Highlights a...
GlobeNewswire 2019-09-27 Global Immune Thrombocytopenia (ITP) Market Expected to Reach $2.27 Billion in 2023, Growing at a CA...
GlobeNewswire 2019-01-24 Market Trends Toward New Normal in SeaWorld Entertainment, Rigel Pharmaceuticals, Guidewire Software...
GlobeNewswire 2018-12-03 New Research Coverage Highlights Weight Watchers International, Rudolph Technologies, Lowe's Compani...
GlobeNewswire 2018-11-05 Extractables and Leachables Testing Services Market, 2028
GlobeNewswire 2018-08-31 New Research Coverage Highlights Argos Therapeutics, Triumph Group, Rigel Pharmaceuticals, Egalet, H...
GlobeNewswire 2018-08-10 Novel Drugs and Smart Devices for Respiratory Disorders, 2030 - Focus on Asthma, COPD and Cystic Fib...
GlobeNewswire 2018-07-27 Recent Analysis Shows Synopsys, Rigel Pharmaceuticals, Fate Therapeutics, Philip Morris Internationa...
GlobeNewswire 2018-03-13 World Novel Drugs and Smart Devices for Respiratory Disorders Market, 2030
GlobeNewswire 2018-02-21 New Research: Key Drivers of Growth for SpartanNash, Nustar GP, Hornbeck Offshore Services, TiVo, El...
GlobeNewswire 2017-12-04 Detailed Research: Economic Perspectives on TiVo, Eli Lilly, Rigel Pharmaceuticals, SpartanNash, Nus...
GlobeNewswire 2017-11-06 Market Trends Toward New Normal in Public Service Enterprise Group, Rigel Pharma, National Oilwell V...
GlobeNewswire 2017-09-05 Aclaris Therapeutics Announces Issuance of Two U.S. Patents Covering JAK Inhibitors for Treating Hai...
GlobeNewswire 2017-05-09 Aclaris Therapeutics Reports First Quarter 2017 Financial Results
GlobeNewswire 2017-05-05 Aclaris Therapeutics Completes Phase 1 Clinical Trial of ATI-50001 for the Treatment of Alopecia Uni...
GlobeNewswire 2017-04-04 Syndax Pharmaceuticals Adds Biopharmaceutical Industry Leader Keith A. Katkin to Board of Directors
GlobeNewswire 2017-03-15 Aclaris Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corpor...
GlobeNewswire 2016-12-07 Aclaris Therapeutics Initiates Phase 1 Clinical Trial for ATI-50001, an Investigational JAK Inhibito...
GlobeNewswire 2009-07-30 BB BIOTECH: Positive development thanks to Genentech and Vertex participations
GlobeNewswire 2009-04-28 Pharma needs biotech for growth